M. Rudwaleit

发表

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

M. Dougados, I. Olivieri, D. M. van der Heijde, 2010, Annals of the rheumatic diseases.

THU0400 CLINICAL COURSE OF EARLY AXIAL SPONDYLOARTHRITIS OVER TEN YEARS: LONG-TERM RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT

J. Sieper, H. Haibel, J. Callhoff, 2020, Annals of the Rheumatic Diseases.

Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis

M. Dougados, I. Olivieri, M. D. de Wit, 2013, Annals of the rheumatic diseases.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

J. Chenot, A. Stallmach, J. Braun, 2014, Zeitschrift für Rheumatologie (Print).

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

J. Braun, J. Sieper, M. Bollow, 1998, Arthritis and rheumatism.

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

M. Dougados, D. M. van der Heijde, R. Landewé, 2009, Annals of the rheumatic diseases.

MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis

J. Braun, J. Listing, J. Sieper, 2007, Annals of the rheumatic diseases.

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

J. Listing, J. Sieper, H. Haibel, 2004, Annals of the rheumatic diseases.

EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

E. Naredo, D. M. van der Heijde, P. Conaghan, 2015, Annals of the rheumatic diseases.

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

M. Dougados, D. M. van der Heijde, R. Landewé, 2009, Annals of the rheumatic diseases.

New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)

M. Dougados, B. Dijkmans, I. Olivieri, 2009, Annals of the rheumatic diseases.

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

M. Dougados, J. Reveille, D. M. van der Heijde, 2013, Annals of the rheumatic diseases.

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Andreas Krause, G. Burmester, A. Krause, 2011, Annals of the rheumatic diseases.

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.

D. M. van der Heijde, W. Golder, J. Braun, 2003, Arthritis and rheumatism.

Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.

J. Braun, J. Brandt, J. Listing, 2005, Rheumatology.

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab

J. Braun, J. Brandt, J. Listing, 2005 .

Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept

J. Braun, J. Brandt, J. Listing, 2005, Annals of the rheumatic diseases.

Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging ( MRI ) – a comparison between contrast enhanced T 1 and short-tau inversion recovery ( STIR ) sequences

D. M. van der Heijde, R. Landewé, D. V. D. Heijde, 2005 .

Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging

D. M. van der Heijde, R. Landewé, J. Braun, 2004, Annals of the rheumatic diseases.

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems

D. M. van der Heijde, W. Golder, J. Braun, 2004, Annals of the rheumatic diseases.

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

D. M. van der Heijde, R. Landewé, D. Heijde, 2009, Annals of the rheumatic diseases.

How to diagnose axial spondyloarthritis early

D. M. van der Heijde, D. Heijde, J. Braun, 2004, Annals of the rheumatic diseases.

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

M. Dougados, B. Dijkmans, I. Olivieri, 2009, Annals of the rheumatic diseases.

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

V. Mazurov, J. Lenaerts, L. Myasoutova, 2013, Annals of the rheumatic diseases.

SAT0389 Long-Term Improvements in Workplace and Household Productivity and Social Participation over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

R. Landewé, J. Braun, A. Kavanaugh, 2016 .

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.

D. M. van der Heijde, J. Braun, J. Listing, 2007, Arthritis and rheumatism.

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

J. Braun, J. Brandt, J. Listing, 2003, Arthritis and rheumatism.

Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study

J. Sieper, M. Rudwaleit, M. Richter, 2007, Annals of the rheumatic diseases.

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

H. Kupper, M. Kron, J. Vanhoof, 2008, Annals of the Rheumatic Diseases.

Impact of anti-tumour necrosis factor α treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis

J. Braun, J. Brandt, J. Listing, 2004, Annals of the rheumatic diseases.

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

D. M. van der Heijde, R. Landewé, D. Heijde, 2016, Arthritis care & research.

OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS

R. Landewé, L. Gensler, H. Marzo-Ortega, 2023, Annals of the Rheumatic Diseases.

Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2

V. Mazurov, J. Lenaerts, L. Myasoutova, 2013, Annals of the rheumatic diseases.

Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care

J. Sieper, M. Rudwaleit, M. Rudwaleit, 2004, Annals of the rheumatic diseases.

Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.

J. Sieper, D. Poddubnyy, M. Rudwaleit, 2008, Arthritis and rheumatism.

Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis

A. Thiel, J. Sieper, M. Rudwaleit, 2004, Annals of the rheumatic diseases.

Challenges in the diagnosis of axial spondyloarthritis

F. V. van Gaalen, M. Rudwaleit, 2023, Best Practice & Research Clinical Rheumatology.

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab

J. Braun, J. Braun, J. Brandt, 2005, Arthritis Research & Therapy.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 5 Initial diagnosis/referral strategy].

A. Heiligenhaus, J. Chenot, B. Swoboda, 2014, Zeitschrift fur Rheumatologie.

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis

J. Braun, J. Brandt, J. Listing, 2004, Annals of the rheumatic diseases.

[Early axial spondyloarthritis. Diagnostic approach and screening].

J. Sieper, D. Poddubnyy, M. Rudwaleit, 2012, Zeitschrift fur Rheumatologie.

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

J. Braun, J. Brandt, J. Listing, 2007, Annals of the rheumatic diseases.

Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change.

J. Braun, J. Listing, J. Sieper, 2009, Arthritis and rheumatism.

Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences

R. Landewé, J. Brandt, X. Baraliakos, 2005, Annals of the rheumatic diseases.

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

M. Dougados, I. Olivieri, R. Landewé, 2010, Annals of the rheumatic diseases.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

J. Chenot, A. Stallmach, A. Stallmach, 2014, Zeitschrift für Rheumatologie.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

B. Swoboda, A. Stallmach, A. Stallmach, 2014, Zeitschrift für Rheumatologie.

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis

M. Dougados, S. van der Linden, I. Olivieri, 2006, Annals of the rheumatic diseases.

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.

J. Braun, J. Brandt, J. Listing, 2005, Rheumatology.

Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy.

J. Häberle, J. Braun, J. Brandt, 1999, Rheumatology.

Radiographic progression in patients with ankylosing spondylitis after two years of treatment with the tumor necrosis factor-α antibody infliximab

J. Brandt, X. Baraliakos, M. Rudwaleit, 2005 .

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

J. Braun, J. Sieper, D. Krause, 2014, Zeitschrift für Rheumatologie.

Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.

J. Braun, J. Listing, J. Sieper, 2010, Arthritis and rheumatism.

Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.

J. Braun, J. Brandt, J. Listing, 2007, Rheumatology.

Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice.

J. Listing, J. Sieper, H. Haibel, 2008, Clinical and experimental rheumatology.

ASAS consensus definition of early axial spondyloarthritis

R. Landewé, L. Gensler, S. Ramiro, 2023, Annals of the Rheumatic Diseases.

Six months open label trial of leflunomide in active ankylosing spondylitis

J. Braun, J. Sieper, H. Haibel, 2004, Annals of the rheumatic diseases.